The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care

Abstract

The study of pharmacogenomics has, by harnessing sequence information from human genomes, the potential to lead to novel approaches in drug discovery, an individualized application of drug therapy, and new insights into disease prevention. For this potential to be realized results need to be interpreted to the prescriber into a format which dictates an action. This mini review briefly describes the history, the regulatory environment, opinions towards, and implementation, integration and interpretation of pharmacogenomics in the United States of America and Europe. The article discusses also how interpretation of pharmacogenomics could move forward to better implementation in health care.

Ethiopian health care professionals’ knowledge, attitude, and interests toward pharmacogenomics

“…These findings were consistent with results from other surveys assessing the pharmacogenomic knowledge among health professionals. 7 – 16 Forty-four (61%) physicians, however, did not think that they are competent enough to discuss the patients’ pharmacogenomic information with other health professionals. This might be due to lack of integration of pharmacogenomics in their medical curriculum and also information gained might be self-directed learning from their colleagues or through internet that may lead to an unequal standard of practice.…”